Company Profiles

driven by the PitchBook Platform

Otic Pharma

Otic Pharma
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Reverse Merger LATEST DEAL TYPE
$4.3M TOTAL AMOUNT RAISED
6 INVESTORS
Description

Developer of drugs for disorders of the ear, nose, and throat (ENT). The company provides products for the treatment of ENT disorders, based on FoamOtic, a proprietary foam-based drug delivery system providing sustained exposure of drugs. Its products includes a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
19900 MacArthur Boulevard
Suite 550
Irvine, CA 92612
United States

+1 (949) 238-8090
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Otic Pharma’s full profile, request a free trial.

Otic Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Reverse Merger 10-May-2017 $4.3M Completed Generating Revenue
3. Early Stage VC 26-Feb-2012 00.00 00.00 Completed Startup
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Otic Pharma Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Incentive Incubator Accelerator/Incubator 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
Peregrine Ventures Venture Capital Minority 000 0000 000000 0
Pontifax Venture Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Otic Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Gregory Flesher Chief Executive Officer, President & Board Member
Christine Ocampo Chief Financial Officer & Senior Vice President
Rodrigo Yelin Ph.D Chief Operating Officer & Head, Research & Development
Catherine Turkel Ph.D Chief Development Officer
Michael Cruse Vice President, Corporate Operations

Otic Pharma Board Members (9)

Name Representing Role Since Contact
Info
Chen Schor Self Board Member 000 0000
Eran Eilat MD Self Board Member 000 0000
Erez Chimovits OrbiMed Board Member 000 0000
Eyal Lifschitz Peregrine Ventures Board Member 000 0000
Gregory Flesher Otic Pharma Chief Executive Officer, President & Board Member 000 0000

1 Former Board Members

You’re viewing 5 of 9 board members. Get the full list »